Malaria Vaccines Market

Malaria Vaccines are used for malaria treatment. Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.

Malaria Vaccines Market contains market size and forecasts of Malaria Vaccines in global, including the following market information:

Global Malaria Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Malaria Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Malaria Vaccines companies in 2021 (%)

The global Malaria Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Pre-Erythrocytic Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Malaria Vaccines include GlaxoSmithKline Plc, Sanaria Inc, Nobelpharma Co, Sumaya Biotech and GenVec, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Malaria Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Malaria Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Malaria Vaccines Market Segment Percentages, by Type, 2021 (%)

• Pre-Erythrocytic Vaccine
• Erythrocytic Vaccine
• Multi-antigen Vaccine

Global Malaria Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Malaria Vaccines Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Community Centers

Global Malaria Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Malaria Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Malaria Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Malaria Vaccines revenues share in global market, 2021 (%)
• Key companies Malaria Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Malaria Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline Plc
• Sanaria Inc
• Nobelpharma Co
• Sumaya Biotech
• GenVec